Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore withdrawal approaches for portfolios with SP 500 and Total Stock Market funds to sustain income and minimize risk.
28,406 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
MicroStrategy remains tethered to Bitcoin moves, but bullish bets persist as the company expands its digital-asset st...
Small-cap value investing can unlock potent upside, but choosing the right ETF matters. This guide compares SLYV and ...
Deribit’s massive options settlement tested Bitcoin’s resilience, with BTC hovering around $60,000 as traders weigh t...
XRP ETFs posted their first weekly red bar after months of inflows, while Bitcoin and Ethereum ETFs logged solid gain...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
Bitcoin and Ether defy a tariff shock, keeping prices steady as markets assess broader implications for crypto liquid...
A January 2026 FHFA release details a two-score, lender-choice framework that could ripple through mortgage pricing, ...
Ethereum stabilizes around $2,100 as real-world asset tokenization accelerates, driving ETH-led growth in the RWA sec...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...
New Galaxy Digital figures show crypto funding falls after the Q4 2025 spike, as Q1 2026 totals pull back though rema...
Bitcoin tumbles under $70,000 as altcoins take the lead in a volatile session. Bitcoin dominance slips, signaling a s...